Duke Health
7
1
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
14.3%
1 terminated/withdrawn out of 7 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
67%
2 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
Role: collaborator
Study of Monochromatic X-ray Mammography System
Role: collaborator
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Role: collaborator
Terbutaline Sulfate in Adults With Asthma
Role: collaborator
Integrated Services for Pain: Interventions to Reduce Pain Effectively
Role: collaborator
Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors
Role: collaborator
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
Role: collaborator
All 7 trials loaded